In 2024, the European Medicines Agency (EMA) conducted over 210 GMP inspections under centralised authorisation procedures, and ten of those inspections resulted in formal GMP non-compliance statements that blocked product access to the EU market. This outcome highlights a broader inspection shift: regulators now focus less on isolated validation deliverables and more on how companies govern validation decisions across systems and time. In practice, inspection teams increasingly test whether Pharma Validation activities follow a coherent strategy, with clear ownership, defined scope, and traceable lifecycle logic. Within this context, the validation master plan (VMP) has become a primary inspection reference, used to assess whether validation governance supports sustainable GMP compliance rather than short-term execution.
Table of Contents
What is a validation master plan (VMP) in a GMP system
A validation master plan defines how an organization governs validation across facilities, systems, and processes under GMP. It sets the boundaries of validation, clarifies accountability, and explains how lifecycle oversight operates in practice.
In regulatory terms, the VMP acts as a control document. Inspectors do not treat it as a summary of protocols. Instead, they use it to verify that validation activities follow a coherent strategy and that decisions remain traceable over time.
The document typically covers system scope, validation approach, lifecycle stages, and governance structure. However, inspectors focus less on format and more on clarity. They expect the VMP to explain why certain systems require validation, how validation depth was defined, and who owns decisions when changes occur.
When a VMP lacks this clarity, validation activities appear fragmented. Consequently, inspectors question whether the organization truly controls its validated state or simply executes tasks.
Why inspectors rely on the validation master plan (VMP) during GMP reviews
Inspectors rely on the validation master plan (VMP) because it gives a clear, single view of validation governance. During GMP reviews, they use it to check alignment between validation strategy and real practice.
Typically, inspectors review the VMP before they examine protocols or reports. Through this document, they quickly assess validation scope, role clarity, and lifecycle oversight.
More importantly, inspectors use the VMP to test decision logic. When validation approaches differ between systems, they expect clear justification. If the rationale remains weak, inspectors often raise governance-level findings.
How inspectors evaluate validation governance using the (VMP)
Inspectors assess validation governance by tracking how decisions move from the VMP into execution and change control. They check alignment between strategy and practice. When decision logic stays clear, inspections run smoothly. When it breaks, inspectors flag wider compliance risks.
The following steps show how inspectors translate validation governance into inspection outcomes across scope, ownership, lifecycle, and change control.
- Step 1 — Scope definition and system boundaries
- Step 2 — Roles, responsibilities, and ownership
- Step 3 — Lifecycle coverage and validation strategy
- Step 4 — Change control and revalidation logic
The infographic below shows how validation governance defined in the VMP translates into concrete inspection outcomes across scope, ownership, lifecycle, and change control
Step 1 — Scope definition and system boundaries
Inspectors first assess whether validation scope reflects actual operations. They compare system lists, process maps, and equipment inventories against the VMP. When systems appear missing or loosely defined, inspectors question whether validation boundaries remain under control.
Clear scope definition signals that the organization understands its processes. Conversely, vague boundaries often suggest reactive validation planning rather than structured governance.
Step 2 — Roles, responsibilities, and ownership
Next, inspectors examine ownership. They look for named roles, decision authority, and escalation paths. When the VMP fails to define who approves validation strategy or who assesses change impact, inspectors often cite accountability gaps.
Strong ownership demonstrates that validation decisions follow governance rather than convenience. Weak ownership, however, increases the risk of inconsistent validation outcomes across departments.
Step 3 — Lifecycle coverage and validation strategy
Inspectors then review lifecycle logic. They expect the VMP to explain how initial qualification connects to ongoing verification, requalification, and process validation. When lifecycle stages appear disconnected, inspectors challenge the sustainability of the validated state.
This review often extends into related systems such as CSV, cleaning validation, and continued process verification, even if those areas have separate documentation.
Step 4 — Change control and revalidation logic
Finally, inspectors focus on change management. They test whether the VMP defines when changes trigger revalidation and how impact assessments operate. When revalidation decisions rely on undocumented judgment, inspectors frequently raise findings related to control of change.
Inspection findings that expose weak VMP governance
When validation governance breaks down, inspection findings tend to follow predictable patterns. Inspectors repeatedly flag similar issues across sites and companies.
The infographic below summarizes the core validation governance elements inspectors consistently review when assessing GMP compliance.
Common inspection observations include:
| Governance gap | Typical inspection finding | Regulatory impact |
|---|---|---|
|
Unclear validation scope |
Systems not covered by validation strategy |
Major observation |
|
Undefined ownership |
No accountable role for validation decisions |
Major observation |
|
Weak lifecycle logic |
Validation not maintained over time |
Critical risk trend |
|
Poor change linkage |
Changes implemented without revalidation |
Escalated follow-up |
These findings rarely arise from missing protocols alone. Instead, they reflect gaps in governance logic that the VMP failed to address.
Maintaining inspection readiness through VMP governance
Organizations that maintain inspection readiness treat the VMP as a living governance tool rather than a static document. They review it periodically, align it with operational changes, and ensure ownership remains current.
Effective governance focuses on sustainability. Teams link validation planning to change control, risk management, and quality oversight. As a result, inspectors see consistent decision-making rather than isolated fixes.
Companies that adopt this approach reduce inspection friction. They also shorten response timelines during audits because validation logic remains documented and defensible.
Download FDA Guidance for Industry – Process Validation: General Principles and Practices Here
Final Words
Recent inspection trends show a clear pattern. Over 30% of repeat GMP observations come from governance weaknesses already identified in earlier audits. As a result, regulators send a strong message. Inspectors now focus less on isolated execution gaps and more on long-term oversight, particularly through structured governance models such as the validation master plan (VMP).
In practice, this shift changes expectations significantly. Companies can no longer rely only on well-written protocols. Instead, inspectors look for clear decision logic, defined ownership, and traceable lifecycle control across validation activities. Moreover, when governance remains fragmented, even technically sound validation efforts fail during repeat inspections. Therefore, organizations must strengthen validation governance to maintain GMP compliance and protect critical regulatory timelines.
Qualification and Validation for GMP Systems
Our team supports the planning, execution, and maintenance of qualification and validation activities, including IQ, OQ, and PQ, to keep GMP-regulated systems compliant and under control.
FAQ
Inspectors look for clear scope definition, accountable roles, lifecycle coverage, and evidence-based change control logic within the VMP
Because fragmented validation decisions usually reflect weak oversight and inconsistencies, not procedural errors alone.
By aligning validation strategy with risk-based planning, linking changes to lifecycle control, and documenting decision logic clearly.
References
Alireza Zarei is the founder and CEO of Zamann Pharma Support GmbH in Germany. He pairs 20 years in GMP—beginning in a lab in 2005—with front-line global project delivery for companies such as Boehringer Ingelheim, Roche, BioNTech, Takeda, Fresenius Medical Care, Biotest, ratiopharm and others. He focuses on innovative validation and qualification procedures, master data management strategies, end-to-end LIMS implementation and care, with pragmatic advice on general Quality Management topics and management level OpEx consulting. Together with his team he also created Pharmuni.com as the leading GMP learning platform in the industry.